The first few weeks to months following the acquisition of HIV are characterized by rapid viral replication and dissemination of the virus throughout the body . During this period of acute infection, high titres of viral RNA are likely to be present in the genital tract as well as in plasma . Notably, during this time most recently-infected persons will test negative or indeterminate on standard HIV antibody tests. Therefore, they are likely to continue to engage in high-risk behaviors such as unprotected intercourse.
Previous studies have demonstrated that persons living with HIV (PLWH) who are unaware of their HIV status are significantly more likely than HIV-status-aware PLWH to engage in practices that place their sexual partners at risk for HIV acquisition [3,4]. Marks et al. estimate that 54% of all sexually-acquired HIV infections in the USA are due to the transmission risk behaviors of PLWH who are unaware of their HIV status . As viral load is elevated by several log units (factors of 10) during the acute phase of infection compared with the asymptomatic stage of infection [1,6], with corresponding increases in the probability of HIV transmission [7,8], acutely-infected persons may be much more likely to transmit HIV to sex partners than are other PLWH who are unaware of their HIV status .
Mathematical modeling studies have suggested that transmission during the brief, high viral load period of acute infection could play a disproportionate role in fueling or sustaining HIV epidemics under certain circumstances [10–12]. The actual impact of acute-phase transmission on the current USA HIV epidemic is not however, known. The present study utilized a simple mathematical model to estimate the number and proportion of sexually-acquired HIV infections that are due to the transmission risk activities of persons with acute infection. These estimates are needed to assist HIV prevention resource allocation decision makers who must determine whether to implement potentially costly strategies to prevent acute-phase transmission (such as HIV RNA testing coupled with enhanced counseling and partner notification programs [13–15]), and to help prioritize research into acute-phase HIV transmission within the context of the larger HIV prevention scientific agenda.
Approximately 25% of the 1 million persons living with HIV in the USA are unaware of their HIV status . Each year an estimated 40 000 people in the USA acquire HIV and pass through the relatively brief period of acute infection . Let T denote the duration of the acute phase of infection, in days. On average, on any given day there are N1 = 40 000 * (T/365) acutely-infected PLWH, N2 = 250 000– 40 000 * (T/365) persons with non-acute infection who are unaware of their HIV status, and N3 = 750 000 serostatus-aware PLWH.
Let γk (k = 1, 2, 3) denote the average number of secondary infections expected, per day, among the sex partners of PLWH in group Nk (γk is the daily ‘HIV transmission rate’ ). The total number of sex partners in the USA who acquire HIV on any given day is then
Equation (Uncited)Image Tools
The proportion of these incident infections that are due to acute-phase HIV transmission is
Equation (Uncited)Image Tools
which also can be written
Equation (Uncited)Image Tools
where μ12 = γ1/γ2 and μ23 = γ2/γ3 are the transmission rate ratios for acutely-infected versus nonacutely infected serostatus-unaware PLWH, and for nonacutely infected, serostatus-unaware versus serostatus-aware PLWH, respectively. Approximately 32 000 persons acquire HIV each year in the USA as a consequence of sexual risk behaviors ; 32 000 * IA of these incident infections are due to acute-phase HIV transmission.
The duration of the acute phase of infection is uncertain and likely varies from one person to the next. On average, detectable plasma viremia first appears about 7 days postinfection, reaches peak concentration 7 to 10 days later, and then decreases to a steady-state, ‘set point’ level within 8 weeks of viral acquisition [9,19,20]. The base-case analysis therefore assumed a 7-week (T = 49 day) period of acute infectiousness, with lower and upper bounds of 6 and 8 weeks (T = 42 and 56, respectively).
Marks et al. estimated that the transmission rate for PLWH who are unaware of their HIV status is 3.47 times larger than the transmission rate for serostatus-unaware PLWH . Their model assumed that serostatus-aware PLWH engage in 57% fewer acts of unprotected intercourse with at-risk (HIV-negative or serostatus-unknown) partners than do serostatus-unaware PLWH; that 60% of serostatus-aware PLWH receive highly-active antiretroviral therapy (HAART); and that 55% of persons on HAART are incapable of transmitting the virus due to plasma viral load levels below 500 copies/ml. As this model did not account for the transmission facilitating effects of acute infection, the 3.47 estimate is best interpreted as the ratio of the transmission rates for nonacutely infected, serostatus-unaware versus serostatus-aware PLWH. Consequently, μ23 was set to 3.47 in the base-case analysis. The sensitivity analyses considered two extreme cases in which μ23 was set to 1.49 (43% of the base-case value), which corresponds to the pessimistic assumption of no behavioral change of any kind after PLWH learn their serostatus, or to 6.94 (twice the base-case value), which corresponds to the possibility that PLWH who are aware of their serostatus might have half as many sex partners as HIV-status-unaware PLWH. Alternatively, this range is sufficient to account for any of a number of deviations from the assumptions of Marks et al. regarding the sexual activity levels of serostatus-aware versus unaware PLWH, the proportion of PLWH on HAART, or the proportion of PLWH for whom HAART has effectively eliminated the potential for transmission.
Little is known regarding the acute-phase transmission rate ratio, μ12 = γ1/γ2. As shown in the explanatory mathematical section that precedes the reference list, however, if the number of sex acts during the acute phase of infection and during a comparable period of nonacute, serostatus-unaware infection (nA and nS, respectively) are not too large, then the ratio nAαA/nSαS provides an approximate upper bound for μ12, where αA and αS, respectively, denote the average per-act transmission probability during the acute phase of infection and the (constant) per-act transmission probability during the nonacute, asymptomatic period of infection. A lower bound of αA/αS = 4.2 was derived from a modeling study of male-to-female HIV transmission perfomed by Pilcher et al.  and an upper bound of 12.0 was obtained from the model of male-to-male sexual transmission developed by Rapatski et al.  (see explanatory mathematical section below). The parameter μ12 was set to the average of these values, 8.1, in the base-case analysis and was varied from 4.2 to 12.0 in the sensitivity analyses. Notably, in comparison with the base-case value, the sensitivity analyses allow for the possibility that acutely-infected persons might engage in 48.1% more or 48.1% fewer unprotected sex acts than do nonacutely infected, serostatus-unaware PLWH in the same period of time.
In the base-case scenario, acute-phase HIV transmission accounted for 2760 (8.6%) of the 32 000 infections that are acquired each year through risky sexual activities. Of the remaining sexually-acquired infections, approximately half (48.5%) were due to transmission from nonacutely infected serostatus-unaware persons and 42.9% were due to serostatus-aware persons (see Table 1).
As indicated in Table 2, the proportion of incident infections due to acute-phase transmission was moderately sensitive to each of three of the main model parameters (μ12, μ23, and T), ranging from 4.7 to 12.3% in univariate sensitivity analyses that varied one of the three parameters while holding the other two at their base-case values. Notably, when μ23 and T were set to their base-case values, the percentage of infections due to acute-phase transmission was approximately equal to the acute-phase transmission rate ratio, μ12. The minimum percentage of infections due to acute-phase transmission, which was obtained when all three parameters were set to their minimum values, was 2.5% and the maximum was 17.3%.
The results of the preceding analysis suggest that approximately 2760 (8.6%) of sexually-acquired HIV infections in the USA are due to acute-phase transmission. Despite the relatively small predicted impact of acute infection on the USA epidemic, this analysis nevertheless highlights the significant risk of HIV transmission during acute infection. The HIV transmission rate for acutely-infected persons was 16 times larger than the overall transmission rate for PLWH in the USA. Although acutely-infected persons may be much more likely than other PLWH to transmit the virus to their sex partners, their relatively small census (approximately 0.5% of all PLWH) and the very brief duration of the acute phase of infection minimizes the impact of acute-phase transmission on the overall HIV epidemic in the USA.
The results of this analysis are consistent with the estimate of Xiradou et al. that 11% of HIV infections among gay men in Amsterdam can be attributed to acute-phase HIV transmission . In the study of HIV transmission in heterosexual Ugandan couples performed by Wawer et al., 43.4% (10/23) of recently-infected persons transmitted the virus to their primary sex partner within an estimated 5 months of seroconverting . This finding is the basis for some commentators' assertion that acute-phase transmission could account for ‘nearly one-half’ of all incident infections . An unpublished modeling study based on these data suggests, however, that despite the elevated risk of HIV transmission during acute infection, acute-phase transmission would account for ‘only’ 11% of new infections in the Ugandan population at epidemic equilibrium .
The findings of the present study are also consistent with previous analyses of the impact of serostatus awareness, which indicate that the annual HIV transmission rate for PLWH who are unaware of their positive serostatus is approximately 3.5 to 3.7 times larger than the transmission rate for HIV-status-aware PLWH [5,25]. Acute-phase HIV transmission accounts for a very small portion of this difference: if acutely-infected persons were no more likely to transmit the virus than other HIV-status-unaware PLWH (i.e., if μ12 = 1), the percentage of infections due to the transmission risk activities of HIV status-unaware persons would decrease only slightly, from 54.8 to 53.6%. Increasing the proportion of PLWH who are aware of their HIV status should remain a high-priority objective of HIV prevention efforts in the USA .
The present analysis is limited by uncertainty in several key parameters, particularly the acute-phase transmission rate ratio. This analysis utilized parameter values drawn from several previous studies, including Marks et al. , Pilcher et al. , and Rapatski et al. , and is subject to the limitations of these previous studies. The results of the multivariate sensitivity analyses—in which the values of key parameters were independently varied over relatively broad ranges—suggest that the impact of acute-phase transmission on the USA epidemic could be much smaller or larger than indicated by the base-case value.
In summary, the results of this study indicate that the proportion of sexually-acquired infections in the US due to acute-phase transmission is not nearly as large as has been suggested by some commentators. Uncertainties notwithstanding, this study provides little support for the assertion that, in the USA, “as many as half of all new infections may be acquired from an index case in the acute phase [of infection]” . Additional research is needed to more precisely determine the overall epidemiological impact of acute-phase HIV transmission in the USA.
Explanation of mathematical techniques
Herein a justification is provided for approximating the transmission rate ratio, μ12 = γ1/γ2, by the ratio nAαA/nSαS, and the derivation of the αA/αS estimates used in the analyses is described. Here, γ1, nA, and αA denote the HIV transmission rate (i.e., the expected number of transmission events per PLWH), the number of unprotected sex acts, and the average per-act transmission probability during the acute phase of infection, whereas γ2, nS, and αS denote the corresponding values for a comparable period of nonacute, serostatus-unaware infection.
An HIV-infected person with m uninfected sex partners would be expected to transmit the virus to γ = β1 + β2 + … + βm of these partners, where βk = 1– (1– α1)(1– α2) … (1– αnk) is the probability of transmission to partner k, nk is the number of unprotected sex acts with partner k, and αi is the transmission probability associated with the i-th sex act (for simplicity we assume that the risk of transmission for condom-protected acts is zero) .
During the asymptomatic phase of infection, the per-act transmission probability is assumed to be constant: αi = αS for i = 1,2, …, nk, and therefore, βk = 1 − (1 − αs)nk. As αS is relatively small (e.g., αS = 0.00055  or αS = 0.002 ), 1– (1– αS)nk ≈ αSnk, and consequently, γ2 = β1 + β2 + … + βm ≈ αSnS, where nS = n1 + n2 + … + nm is the total number of unprotected sex acts, summed across partners.
More generally, βk = 1– (1– α1)(1– α2) … (1– αnk) ≤ α1 + α2 + … + αnk, and therefore γ ≤ Σαi, where the sum is taken over all sex acts with all partners. If the nA acts during the acute phase of infection are evenly or randomly distributed throughout this period, then Σαi ≈ nAαA, where αA is the average per-act transmission probability during the acute phase of infection. Thus, on average, γ1 ≤ nAαA and μ12 = γ1/γ2 ≤ nAαA/nSαS.
Estimates of αA/αS were obtained from Rapatski et al. , who estimated the per-act transmission probability during male-to-male receptive anal intercourse at αA = 0.024 for the acute phase of infection and αS = 0.002 for asymptomatic infection (hence, αA/αS = 12.0), and from Pilcher et al.  The latter study estimated the set point per-act transmission probability for male–female intercourse at αS = 0.00055 and the overall probability of transmission from an acutely-infected male to his female sex partner during the acute phase of infection at pA = 0.032, assuming eight unprotected sex acts per month over a 55-day period; this is approximately n = 14 total acts of intercourse over a 7-week period of acute infectiousness (i.e., excluding the approximately 7-day noninfectious latency period before detectable viremia appears). The average per-act transmission probability during the acute phase of infection was derived from this estimate using the equation: αA = 1– (1– pA)1/n. The resultant estimate of αA/αS equaled 4.2 (0.00055/0.0023).
This research was supported by grants R01-MH077511 and P30-MH52776 from the National Institute of Mental Health. The author thanks Leah Przedwiecki and Ralph Resenhoeft for their assistance in background research and manuscript preparation.
1. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998; 339:33–39.
2. Kahn JO, Hecht F, Warmerdam M, Liu L, Grant, RM. Acute infection: Resistance, fitness, and transmission. Proceedings of the Ninth Conference on Retroviruses and Opportunistic Infections, 2002.
3. Marks G, Crepaz N, Senterfitt W, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 2005; 39:446–453.
4. Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effect of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985–1997. Am J Public Health 1999; 89:1397–1405.
5. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20:1447–1450.
6. Kaufmann GR, Cunningham P, Kelleher AD, Zaunders J, Carr A, Vizzard J, et al. Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. J Infect Dis 1998; 178:1812–1815.
7. Chakraborty H, Sen PK, Helms RW, Vernazza PL, Fiscus SA, Eron JJ, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001; 15:621–627.
8. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921–929.
9. Pilcher CD, Tien HC, Eron JJ Jr, Vernazza PL, Leu SY, Stewart PW, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004; 189:1785–1792.
10. Jacquez JA, Koopman JS, Simon CP, Longini IM. Role of the primary infection in epidemic of HIV infection in gay cohorts. J Acquir Immune Defic Syndr Hum Retrovirol 1994; 7:1169–1184.
11. Koopman JS, Jacquez JA, Welch GW, Simon CP, Foxman B, Pollock SM, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:249–258.
12. Pinkerton SD, Abramson PR. Implications of increased infectivity in early-stage HIV infection: Application of a Bernoulli-Process model of HIV transmission. Evaluation Review 1996; 20:516–540.
13. Cates W, Chesney MA, Cohen MS. Primary HIV infection– a public health opportunity. Am J Public Health 1997; 87:1928–1930.
14. Cohen MS, Pilcher CD. Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis 2005; 191:1391–1393.
15. Pilcher CD, Eaton L, Kalichman S, Bisol C, da Silva de Souza. Approaching HIV elimination: Interventions for acute infection. Current HIV/AIDS Reports 2006; 3:150–158
16. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. Proceedings of the National HIV Prevention Conference, Atlanta, GA, 2005 [abstract: T1-B1101]
17. Centers for Disease Control and Prevention. Epidemiology of HIV/AIDS– United States, 1981–2005. MMWR Morb Mortal Wkly Rep 2006; 55(21):589–597
18. Holtgrave DR. Estimation of annual HIV transmission rates in the United States, 1978–2000. J Acquir Immune Defic Syndr Hum Retrovirol 2004; 35:89–92.
19. Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997; 102:117–124, 125–126.
20. Lindbäck S, Karlsson AC, Mittler J, Blaxhult A, Carlsson M, Briheim G, et al. Viral dynamics in primary HIV-1 infection. AIDS 2000; 14:2283–2291.
21. Rapatski BL, Suppe F, Yorke JA. HIV epidemics driven by late disease stage transmission. J Acquir Immune Defic Syndr 2005; 38:241–253.
22. Xiradou M, Geskus R, de Wit J, Coutinho R, Kretzschmar M. Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men. AIDS 2004; 18:1311–1320.
23. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403–1409.
24. Hollingsworth T, Anderson RM, Fraser C. Has the role of primary HIV been overstated? Presented at 13th Conference on Retroviruses and Opportunistic Infections Denver CO, February 2006 [abstract 913]
25. Holtgrave DR, Pinkerton SD. Can increasing awareness of HIV seropositivity reduce infections by 50% in the United States? J Acquir Immune Defic Syndr 2007; 44:360–363.
26. Centers for Disease Control and Prevention. HIV Prevention Strategic Plan through 2005. Atlanta: Centers for Disease Control and Prevention; 2001. pp. 1–81.
27. Association of State and Territorial Health Officials. Acute HIV infection– An opportunity to enhance primary prevention. ASTHO Bulletin 2006; March:1–16.
28. Pinkerton SD, Abramson PR, Kalichman SC, Catz SL, Johnson-Masotti AP. Secondary HIV transmission rates in a mixed-gender sample. Int J STD AIDS 2000; 11:38–44.
29. Pinkerton SD, Abramson PR. The Bernoulli-Process model of HIV transmission, applications and implications. In: Holtgrave DR, editor. Handbook of Economic Evaluation of HIV Prevention Programs. New York: Plenum Press; 1998. pp. 13–31.
© 2007 Lippincott Williams & Wilkins, Inc.